# Kent L. Wellish, M.D. – FDA Inspection, Feb 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/kent-l-wellish-md/33dfc440-11ad-4d13-a4c0-c7d434adf0ec
Source feed: FDA_Inspections

> FDA inspection 1197198 of Kent L. Wellish, M.D., February 13, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197198
- Company Name: Kent L. Wellish, M.D.
- Inspection Date: 2023-02-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/rebecca-t-davis/a821f7ef-0c73-4be1-9a9b-3fc2c07f88c1)

Company: https://www.keypedia.com/companies/kent-l-wellish-md/d80778cd-9450-4e54-b47f-ff9537f29c21

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
